Turkish Journal of Medical Sciences
Volume 42

Number 6

Article 13

1-1-2012

The effect of REM sleep behaviour disorder on clinical severity in
Parkinson's disease
DURSUN AYGÜN
YAKUP TÜRKEL
ADEM AKKURT
MUSA KAZİM ONAR

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
AYGÜN, DURSUN; TÜRKEL, YAKUP; AKKURT, ADEM; and ONAR, MUSA KAZİM (2012) "The effect of REM
sleep behaviour disorder on clinical severity in Parkinson's disease," Turkish Journal of Medical Sciences:
Vol. 42: No. 6, Article 13. https://doi.org/10.3906/sag-1105-35
Available at: https://journals.tubitak.gov.tr/medical/vol42/iss6/13

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Original Article

Turk J Med Sci
2012; 42 (6): 1033-1038
© TÜBİTAK
E-mail: medsci@tubitak.gov.tr
doi:10.3906/sag-1105-35

The effect of REM sleep behaviour disorder on clinical severity
in Parkinson’s disease
Dursun AYGÜN1, Yakup TÜRKEL2, Adem AKKURT3, Musa Kazım ONAR1

Aim: Differently from previous studies that directly compared Parkinson’s disease (PD) patients with and without
rapid eye movement (REM) sleep behavioural disorder (RBD) for the stage, severity, and duration of disease, this study
investigated the relationship between the duration and clinical severity of disease in PD patients with and without RBD.
Materials and methods: This retrospective study consisted of 141 PD patients older than 18 years of age. The clinical
diagnosis of RBD was based on the minimal diagnostic criteria of the revised 2001 International Classification of Sleep
Disorders. The patients were divided into 2 subgroups, those with and without clinical RBD. The groups were then
compared with each other for sex, age, the duration of disease, and the Hoehn and Yahr stage and Unified Parkinson’s
Disease Rating Scale scores. The correlation between the duration of disease and the clinical severity of PD was analysed
in all patients.
Results: There was no significant difference between the groups in terms of sex, age, disease duration, and clinical
severity scores. For the RBD patients there was a weak positive correlation between the duration of PD and clinical
severity scores. However, there was no such correlation in the non-RBD (NRBD) subgroup.
Conclusion: Our study indicates that in PD patients with RBD compared with NRBD patients, the time taken to reach
the same clinical severity scores may be shorter.
Key words: Parkinson’s disease, REM sleep behavioural disorder, clinical severity, the duration of Parkinson’s disease,
the Unified Parkinson’s Disease Rating Scale, Hoehn and Yahr stage

Introduction
Rapid eye movement (REM) sleep behavioural
disorder (RBD) is characterised by the presence of
abnormal body and limb movements such as hitting,
and vocalisations such as talking, shouting, crying,
and laughing. These are associated with dream
mentation due to a loss of muscle atonia during REM
sleep (1-4). It has been reported that RBD is seen in
up to two-thirds of patients with Parkinson’s disease
(PD) (5). There is evidence that PD patients with
RBD have a more nontremor predominant type (6)
and more nonmotor symptoms than those without
RBD (7); therefore, they exhibit a worse prognosis.

Emre et al. (7) reported that RBD is a risk factor
for developing PD dementia. Many studies have
demonstrated that PD patients with RBD had longer
disease durations and higher clinical severity scores
(1,3,5,8). Contrary to these studies, a recent study
(9) reported that there was no difference between
PD patients with and without RBD in regards to the
initial motor symptoms, duration, and Hoehn and
Yahr (HY) stage of the disease, and the development
of dementia. Thus, the relationship between RBD and
other clinical features of PD such as PD dementia,
duration, stage, and severity of disease has remained
controversial. On the other hand, in previous studies,
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patients with and without RBD had differing disease
durations. It is very important to consider the
duration of disease in the assessment of the clinical
severity of PD, because PD is a progressive disease.
In contrast to the previous studies that directly
compared patients with and without RBD for the
stage, severity, and duration of disease, we investigated
the relationship between the duration and clinical
severity of PD in patients with and without RBD. Our
hypothesis was that for similar disease durations,
PD patients with RBD may have higher Unified
Parkinson’s Disease Rating Scale (UPDRS) scores
and HY stages than those without RBD.
Materials and methods
This retrospective study was approved by the local
ethics committee of our university. Patients with PD
who were older than 18 years of age (n = 147) and
who attended the neurology clinic of the university
hospital during the period between November 2008
and September 2010 were chosen for inclusion in this
study.
Since November 2008, in our polyclinic, PD
patients have been examined by a neurologist (D.A.)
who is experienced in movement disorders. For each
patient, a detailed history of motor and nonmotor
symptoms (including RBD) of PD was obtained, and
the clinical condition was rated with the HY and
UPDRS (motor/total) scores assessed in the ‘ON’
state. All of the following clinical signs associated
with RBD were noted in their history: talking, crying
out, swearing, laughing, shouting, waking the partner,
physical restlessness, punching, kicking, hitting, and
falling out of bed while asleep.
The clinical diagnosis of RBD was based on the
minimal diagnostic criteria of the 2001 revised
International Classification of Sleep Disorders
(ICSD-R), which included limb or body movements
associated with dream mentation and at least one of
the following: harmful or potentially harmful sleep
behaviours; dreams that appear to be “acted out”;
or sleep behaviours that disrupted sleep continuity
(1,3,5,8-10).
Diagnosis of PD was based on the United Kingdom
Brain Bank’s criteria as bradykinesia in association
with rest tremor, rigidity, or postural instability (11).
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All of these data from the PD patients had
been recorded in a computer program and were
reanalysed for this study. The patients were divided
into 2 subgroups, those with and without clinical
RBD. Patients were called by a researcher (A.A.) for
their latest clinical status.
All PD patients with and without clinical RBD
were included in this study. Exclusion criteria were as
follows: 1) single patients; 2) patients whose disease
duration could not be determined with any certainty;
3) patients without a good history (e.g., partner’s
report) of the motor behaviour and vocalisations
during REM sleep; 4) patients whose HY stage
and UPDRS scores in the ‘ON’ state could not be
determined; and 5) patients whose duration and
clinical severity (i.e. HY stage and UPDRS scores) of
PD could not be determined simultaneously.
Statistical analysis
Statistical analysis was performed by Y.B. The
results were analysed using SPSS 15.0. P < 0.05 was
considered statistically significant in all tests. Because
the data were nonnormally distributed, the statistical
analysis was performed using nonparametric tests
(i.e. Mann-Whitney and chi-square tests) to compare
variables of the 2 groups in our study.
Groups 1 (patients with RBD) and 2 (non-RBD
patients; NRBD) were compared to each other for
sex, age, the duration of disease, and the HY stage
(both overall stage score and any score of >2) and
UPDRS scores. A regression correlation test was
used to analyse the correlation between the duration
of and the clinical severity (i.e. UPDRS and HY stage
scores) of PD in all patients.
Results
The study excluded 6 out of the 147 recruited patients
because they met the exclusion criteria. Thus, 141
PD patients were assessed according to the ICSD-R
minimal clinical diagnostic criteria for RBD. For
the 141 PD patients (91 men, 50 women), the mean
age at admission was 66.36 ± 10 years. There were
90 patients with RBD (64%) and 51 patients without
RBD (36%). The mean age at admission was 65.00 ±
12 years in the NRBD group and 67.14 ± 9.9 years in
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the RBD group. There was no significant difference
among the RBD and NRBD groups in terms of sex
and mean age (P = 0.604; df = 1 and P = 0.416,
respectively; Table).
The mean duration of disease did not differ
between the subtypes (5.7 ± 5 versus 5.1 ± 4, P =
0.451; Table). The mean UPDRS scores (total/motor)
were 39.94 ± 20/23.6 ± 12 in the RBD group and 35.82
± 25/22.15 ± 14 in the NRBD group (P = 0.057 and P
= 0.200, respectively; Table). A stage score of >2 was
significantly more common in the RBD group than
in the NRBD group (64.4% versus 45.1%, P = 0.04;
df = 1; Table). Figure 1 shows the relation between
the duration of PD and the HY stage score in the
RBD and NRBD subgroups. For the RBD patients,
there was a weak positive correlation between the
duration of PD and the HY stage score (r = 0.319; P =
0.002; r² = 0.102). Similarly, there was a weak positive
correlation between the duration of PD and UPDRS
(motor and total) scores in the RBD group (r = 0.309,
P = 0.003, and r² = 0.095; r = 0.296, P = 0.005, and r²
= 0.087, respectively; Figures 1 and 2). There was no
correlation between the duration of PD and clinical
severity scores in the NRBD subgroup (Figures 1-3).
Discussion
In the literature, there are studies comparing RBD
and NRBD groups of PD patients for demographic
features, disease duration, UPDRS scores, and
HY stages (3,5,6,8,9,12). Lee et al. (5) reported
that patients with RBD had a longer duration of

PD symptoms and higher UPDRS scores and HY
stages compared to those without RBD. Yoritaka et
al. (9) demonstrated that the duration of PD was
significantly longer in patients with RBD than those
without (P = 0.013), but there was no difference
between RBD and NRBD patients for mean stage
scores (3.0 ± 0.6 and 2.8 ± 0.6, respectively; P = 0.05).
Scaglione et al. (3) reported that RBD patients had
longer disease duration and higher HY stage scores
than NRBD patients. Gjerstad et al. (8) found that
disease duration was longer (11.1 years) in RBD
patients than in NRBD patients (8.6 years). In their
study, the motor and stage scores of RBD patients,
compared with NRBD patients, were also higher (8).
In a study using polysomnography, patients with RBD
were compared with those without RBD, and the RBD
patients’ UPDRS scores were higher (12). Contrary to
other studies, Postuma et al. (6) found no significant
differences in regards to disease duration and
UPDRS scores between NRBD patients and patients
who had polysomnography-confirmed RBD. Thus, in
the literature, the data from studies comparing RBD
and NRBD groups for disease duration, UPDRS,
and HY stage are inconsistent. In these studies, it
has also been seen that patients with and without
RBD, compared for the clinical severity of PD, have
different disease durations. In contrast to previous
studies, we assessed the relationship between disease
duration and the clinical severity of PD in the RBD
and NRBD groups. In this study, in the RBD subtype
the duration of PD was correlated with both the
UPDRS scores (total/motor) and the stage of disease.

Table. Clinical features of PD in the RBD and NRBD subtypes of PD.
Subtypes

Features
Male
Female

RBD (n = 90)
% (n)

60.8 (31)

P
NS

33.3 (30)

39.2 (20)

NS

Age (years)

Mean ± SD

67.14 ± 9.9

65.00 ± 12

NS

UPDRS III

Mean ± SD

23.6 ± 12

22.15 ± 14

NS

UPDRS Total

Mean ± SD

39.94 ± 20

35.82 ± 25.

NS

64.4 (58)

45.1 (23)

0.04

5.7 ± 5

5.1 ± 4

NS

Hoehn and Yahr score of >2
Disease duration (tears)

% (n)

66.7 (60)

NRBD (n = 51 )

% (n)
Mean ± SD

NS: Nonsignificant; UPDRS III: Unified Parkinson’s Disease Rating Scale section III; RBD: rapid eye movement (REM) sleep behavioural
disorder.
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Groups
RBD
NRBD
RBD
NRBD

5.00
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4.00
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R Sq Linear = 0.102
R Sq Linear = 0.016
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10.00 15.00
Duration (years)
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Figure 1. The relation between the duration of PD and the HY stage.
Linear regression analysis was performed separately in the RBD
(r = 0.319; r² = 0.102; P = 0.002) and NRBD (r = 0.125; r² =
0.016; P = 0.303) patients.

However, this correlation was not seen with the
NRBD subtype. Thus, we found higher UPDRS scores
and HY stages in the RBD patients compared with
NRBD patients who had the same disease duration.
This status may be related to the evidence that RBD

patients have more motor and nonmotor symptoms
and, accordingly, a more widespread involvement of
the central nervous system (CNS) structure for the
same disease duration. These results may indicate
that RBD patients exhibit a more rapid progression
Groups

RBD
NRBD
RBD
NRBD

120.00
100.00

UPDRST

80.00
60.00
40.00
20.00

R Sq Linear = 0.095
R Sq Linear = 0.018

0.00
0.00

5.00

10.00
15.00
Duration (years)

20.00

25.00

Figure 2. Regression analysis of UPDRS total (UPDRST) score versus
duration in the subgroups. The intermittent line represents the RBD
group and shows a correlation of increasing UPDRST scores with
increasing duration (r = 0.309; r2 = 0.095; P = 0.003). However, in
the NRBD group (solid line), there was no correlation of UPDRST
scores with duration (r = 0.134; r2 = 0.018; P = 0.347).
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Groups
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Figure 3. Regression analysis of UPDRS motor (UPDRSM) score versus
duration in the subgroups. The intermittent line represents the RBD
group and shows a correlation of increasing UPDRSM scores with
increasing duration (r = 0.296; r2 = 0.087; P = 0.05). However, in
the NRBD group (solid line), there was no correlation of UPDRSM
scores with duration (r = 0.125; r2 = 0.016; P = 0.383).

of PD than NRBD patients. In our study, a stage score
of >2 was significantly more common in the RBD
group than the NRBD group (64.4% versus 45.1%; P
= 0.04; df = 1). However, the duration of PD was not
different between the subtypes (mean: 5.7 ± 5 versus
5.1 ± 4; P = 0.451). The last 2 findings also suggest
that RBD patients have a worse prognosis than those
with the NRBD subtype. The relation to parkinsonian
degeneration in the brainstem nuclei regulating REM
sleep of RBD is well known (2). It is believed that
the pathophysiology of RBD involves the nucleus
reticularis magnocellularis and peri-locus coeruleus
in the pons and the pedunculopontine nucleus in the
mesopontine area (1,13-15). It has been suggested
that RBD may precede the onset of motor symptoms
(1,2,3,8,16). The Braak staging theory suggests that
neuronal degeneration (i.e. Lewy body pathology)
begins in the medulla and progresses upwards (e.g.,
to the neocortex) in PD (17). According to this
theory, RBD corresponds to the second-stage of
Braak, followed by the motor signs of PD (13,17).
The motor signs of PD occur when the substantia
nigra (Stage 3) is affected (17). On the other hand,
it has been reported that RBD is associated with an

increased risk of the development of other nonmotor
symptoms (7,18). This may indicate that when RBD
patients develop PD, they have a more widespread
involvement of the CNS structures than in those
without RBD, including the areas responsible for
RBD in the brainstem. Therefore, it is possible that
PD patients with RBD have an increased number of
motor and nonmotor symptoms associated with the
increased clinical severity of PD, as suggested in many
studies (5,8,9). Finally, these results may indicate that
the time taken to progress from the onset of motor
symptoms to disability will be shorter in PD patients
with RBD than in those without RBD.
The most important limitation of this study was
the use of the ICSD-R minimal diagnosis criteria
without polysomnography to diagnose RBD. The new
diagnostic criteria of RBD, according to the ICSD
2005, requires polysomnographic documentation
of normal skeletal muscle atonia loss in REM sleep
(4,19). However, many recent studies of PD have
used the ICSD-R minimal diagnostic criteria and
do not require a polysomnographic examination for
the clinical diagnosis of RBD, as in the present study
(3,5,8,9).
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Our study indicates that in PD patients with RBD,
compared to those without RBD, the time taken to
reach the same clinical severity scores may be shorter.
Thus, in PD patients with RBD the disease may have
a more rapid progression; hence, they have a worse
prognosis than those without RBD.
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